Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | 3 | 6 | 6 | — | — | 14 |
Lymphoma | D008223 | — | C85.9 | 3 | 6 | 3 | — | — | 9 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 3 | 3 | 1 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-hodgkin lymphoma | D008228 | — | C85.9 | 4 | 4 | — | — | 1 | 6 |
Leukemia | D007938 | — | C95 | 3 | 4 | — | — | — | 5 |
B-cell lymphoma | D016393 | — | — | 1 | 2 | — | — | — | 2 |
Philadelphia chromosome | D010677 | — | — | 1 | 1 | — | — | — | 1 |
Precursor t-cell lymphoblastic leukemia-lymphoma | D054218 | — | — | 1 | 1 | — | — | — | 1 |
Follicular lymphoma | D008224 | — | C82 | 1 | 1 | — | — | — | 1 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 1 | 1 | — | — | — | 1 |
Waldenstrom macroglobulinemia | D008258 | HP_0005508 | C88.0 | — | 1 | — | — | — | 1 |
Drug common name | Epratuzumab |
INN | epratuzumab |
Description | Epratuzumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | >5VKK:H,A|Epratuzumab Fab Heavy Chain
QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYWLHWVRQAPGQGLEWIGYINPRNDYTEYNQNFKDKATITADESTNTAY
MELSSLRSEDTAFYFCARRDITTFYWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSG
ALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC
>5VKK:L,B|Epratuzumab Fab Light Chain
DIQLTQSPSSLSASVGDRVTMSCKSSQSVLYSANHKNYLAWYQQKPGKAPKLLIYWASTRESGVPSRFSGSGSGTDFTLT
ISSLQPEDIATYYCHQYLSSWTFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQ
SGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
PDB | 5VKK, 5VL3 |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108404 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB04958 |
UNII ID | 3062P60MH9 (ChemIDplus, GSRS) |